Financials
- Market Capitalization 540.95 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.25
ratio cours/chiffre d'affaires
1.9
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2433 | CSTL Castle Biosciences, Inc. - Common stock | 33.59 USD | +1.70% | -2.98% | +20.70% | +36.46% | 1.03 B USD | ||
| 2520 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 6.00 USD | -0.83% | -8.81% | +15.61% | +209.28% | 883.19 M USD | ||
| 3008 | PRE Prenetics Global Limited - Class A Ordinary Share | 25.17 USD | -4.11% | +10.49% | +29.41% | +218.61% | 424.72 M USD | ||
| 3344 | MYGN Myriad Genetics, Inc. - Common Stock | 3.02 USD | -6.21% | -5.03% | +5.59% | -63.48% | 288.86 M USD |